ES2380168T3 - Solución de diálisis peritoneal que contiene carnitina y que tiene biocompatibilidad mejorada - Google Patents

Solución de diálisis peritoneal que contiene carnitina y que tiene biocompatibilidad mejorada Download PDF

Info

Publication number
ES2380168T3
ES2380168T3 ES06708437T ES06708437T ES2380168T3 ES 2380168 T3 ES2380168 T3 ES 2380168T3 ES 06708437 T ES06708437 T ES 06708437T ES 06708437 T ES06708437 T ES 06708437T ES 2380168 T3 ES2380168 T3 ES 2380168T3
Authority
ES
Spain
Prior art keywords
vol
carnitine
glucose
solution according
peritoneal dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06708437T
Other languages
English (en)
Spanish (es)
Inventor
Arduino Arduini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2380168T3 publication Critical patent/ES2380168T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
ES06708437T 2005-03-10 2006-02-22 Solución de diálisis peritoneal que contiene carnitina y que tiene biocompatibilidad mejorada Expired - Lifetime ES2380168T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10
WOPCT/IT2005/000130 2005-03-10
PCT/EP2006/060162 WO2006094900A1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Publications (1)

Publication Number Publication Date
ES2380168T3 true ES2380168T3 (es) 2012-05-09

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06708437T Expired - Lifetime ES2380168T3 (es) 2005-03-10 2006-02-22 Solución de diálisis peritoneal que contiene carnitina y que tiene biocompatibilidad mejorada

Country Status (19)

Country Link
US (1) US20080138443A1 (https=)
EP (1) EP1858504B1 (https=)
JP (2) JP4717110B2 (https=)
KR (1) KR101324920B1 (https=)
AR (1) AR054015A1 (https=)
AT (1) ATE539742T1 (https=)
CA (1) CA2599252C (https=)
CY (1) CY1112794T1 (https=)
DK (1) DK1858504T3 (https=)
ES (1) ES2380168T3 (https=)
HR (1) HRP20120177T1 (https=)
ME (1) ME02948B (https=)
MX (1) MX2007010814A (https=)
PL (1) PL1858504T3 (https=)
PT (1) PT1858504E (https=)
RS (1) RS52237B (https=)
SI (1) SI1858504T1 (https=)
TW (1) TWI388318B (https=)
WO (1) WO2006094900A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
JP2001513370A (ja) * 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
ATE336243T1 (de) * 1999-10-11 2006-09-15 Sigma Tau Ind Farmaceuti Verwendung von l-carnitin und seinen alkanoyl- derivaten als osmotisches mittel in lösungen für medizinische verwendung
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
WO2004052269A1 (en) 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica

Also Published As

Publication number Publication date
HRP20120177T1 (hr) 2012-03-31
JP4717110B2 (ja) 2011-07-06
JP5366894B2 (ja) 2013-12-11
EP1858504A1 (en) 2007-11-28
RS52237B (sr) 2012-10-31
JP2008532601A (ja) 2008-08-21
ME02948B (me) 2012-10-31
CY1112794T1 (el) 2016-02-10
US20080138443A1 (en) 2008-06-12
PT1858504E (pt) 2012-04-10
SI1858504T1 (sl) 2012-04-30
KR101324920B1 (ko) 2013-11-01
AR054015A1 (es) 2007-05-30
ATE539742T1 (de) 2012-01-15
WO2006094900A1 (en) 2006-09-14
MX2007010814A (es) 2007-11-07
CA2599252C (en) 2013-07-30
JP2010207630A (ja) 2010-09-24
EP1858504B1 (en) 2012-01-04
DK1858504T3 (da) 2012-04-30
CA2599252A1 (en) 2006-09-14
TW200714279A (en) 2007-04-16
PL1858504T3 (pl) 2012-05-31
KR20070116630A (ko) 2007-12-10
TWI388318B (zh) 2013-03-11

Similar Documents

Publication Publication Date Title
ES2272304T5 (es) Solución basada en bicarbonato en dos partes para la diálisis peritoneal o como solución de sustitución en terapias de perfusión renal
CN105899213B (zh) 氧化胆固醇硫酸酯(ocs)的方法
ES2256981T3 (es) Fluido para dialisis peritoneal que contiene albumina.
ES2274438T3 (es) Uso de una compsicion farmaceutica que contiene acido lactico o lactato y potasio para tratar edema cerebral o lesiones cerebrales.
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
ES2738914T3 (es) Composición acuosa hipotónica con bajo contenido de cloruro, con o sin fosfolípidos
CN103153298A (zh) 用于改善胃肠功能的材料和方法
BRPI0917661B1 (pt) produto, composição farmacêutica e uso da combinação de macitentan com um composto que é dotado de propriedades agonistas do receptor de prostaciclina
ES2270620T3 (es) Uso de l-carnitina y sus derivados alcanoilo como agentes osmoticos en soluciones para uso medico.
US20090062387A1 (en) Method of preventing nephrocalcinosis
ES2906262T3 (es) Composiciones para el tratamiento de la autodigestión
RS52737B (sr) Roscovitine za lečenje izvesnih cističnih bolesti
CA2631740A1 (en) Methods and compositions for the treatment of disease
ES2380168T3 (es) Solución de diálisis peritoneal que contiene carnitina y que tiene biocompatibilidad mejorada
JP2000038348A (ja) アルブミン含有腹膜透析液
KR100778611B1 (ko) 복막투석용 조성물
ES2396650B2 (es) Uso de una composición en la elaboración de una solución de diálisis para el tratamiento de las enfermedades cerebrovasculares mediante diálisis peritoneal.
Thompson et al. Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia
Valeri et al. Red cell 2, 3 DPG, ATP, and creatine levels in preserved red cells and in patients with red cell mass deficits or with cardiopulmonary insufficiency
US20220168337A1 (en) Producing atp and improving mitochondrial function in a mammal using a poly-oxygenated metal hydroxide
ES2380913T3 (es) Uso de L-carnitina para el tratamiento de enfermerdades cardiovasculares
CN101365452A (zh) 治疗疾病的方法和组合物
WO2011083490A2 (en) Stable veterinary composition for enhanced phosphorous uptake
Thomas The Effect of Chlorpromazine on Myocardial Function and Metabolism Following Ischemia and Zero-calcium Injury
Prokurat et al. Continuous Renal Replacement Therapy in children with acute renal failure-own experience